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Summary
Hemoglobin is an important nutrient source for intraerythrocytic malaria organisms. Its catabolism
occurs in an acidic digestive vacuole. Our previous studies suggested that an aspartic protease
plays a key role in the degradative process. We have now isolated this enzyme and defined its
role in the hemoglobinolysic pathway. Laser desorption mass spectrometry was used to analyze
the proteolytic action of the purified protease. The enzyme has a remarkably stringent specificity
towards native hemoglobin, making a single cleavage between tx33Phe and 34Leu. This scission
is in the hemoglobin hingeregion, unraveling the molecule and exposing other sites for proteolysis.
The protease is inhibited by pepstatin and has NH2-terminal homology to mammalian aspartic
proteases. Isolated digestive vacuoles make a pepstatin-inhibitable cleavage identical to that of
the purified enzyme. The pivotal role of this aspartic hemoglobinase in initiating hemoglobin
degradation in the malaria parasite digestive vacuoles is demonstrated.
T
he intraerythrocytic malaria parasite develops within a
cell that contains a single major cytosolic protein, he-
moglobin. The organism avidly ingests host hemoglobin and
degrades it in a specialized proteolytic organelle called the
digestive vacuole (1-4). As the parasite has a limited capa-
bility for de novo synthesis (5, 6) or exogenous uptake (7)
of amino acids, the hemoglobin is catabolized to provide amino
acids for growth and maturation (6, 8, 9). The process of
hemoglobin breakdown releases heme, which is detoxified
by polymerization into a crystalline pigment, hemozoin (10,
11). It has been estimated that 25-75% of hemoglobin in
the infected erythrocyte is degraded (12-15) . To account for
this enormous amount of protein breakdown that occurs in
just a few hours of the parasite's trophozoite stage, we have
proposed that there is an efficient and specific pathway for
hemoglobin proteolysis in the digestive vacuole (16). Several
putative malaria hemoglobinases have been described (17-26),
but it has been difficult to ascribe a physiological role in
hemoglobinolysis to any of these activities. We have recently
reported the purification and characterization ofPlasmodium
falciparum digestive vacuoles in which the degradation ofhe-
moglobin occurs (16). The isolated vacuoles were capable of
cleaving hemoglobin to small fragments, and required action
of an endogenous aspartic protease to cleave intact hemoglobin
before other proteolytic activities could function efficiently.
We have now defined the role of this aspartic hemoglobinase
in the process of hemoglobin catabolism within the diges-
tive vacuole.
Materials and Methods
Materials.
￿
Saponin, Triton X-100, and bovine spleen cathepsin
D were from Sigma Chemical Co. (St. Louis, MO); Centricon filter
units were from Amicon Corp. (Danvers, MA); Immobilon-P
(PVDF) membranes were from Millipore Corp. (Bedford, MA);
DEAE-Sephacel was from Pharmacia Fine Chemicals (Piscataway,
NJ); the 200 SW gel filtration column came from Waters Chro-
matographyDivision (Milford, MA); Ultrogel-HA was a product
of LKB Instruments, Inc. (Gaithersburg, MD); Guanidine HCl
was from Pierce Chemical Co. (Rockford, IL). 3H-Hemoglobin
was prepared by metabolic labeling of rat reticulocytes with r,-3,4,
5'H-leucine (New England Nuclear, Boston, MA) as described
(16). Humanhemoglobin was purifiedfrom normal peripheralblood
(27) and stored at -70°C until use.
Parasite Culture.
￿
P .falciparum clone HB-3 was cultured in A*
human erythrocytes by the method ofTrager andJensen (28). Cul-
ture synchrony was maintained by sorbitol treatment (29), and cells
were harvested at the late trophozoite stage.
Parasite Extract Preparation.
￿
Cultures (600 ml, 5% hematocrit,
15% parasitemia) were harvested by centrifugation for 10 min at
1,500 g, washed twice with PBS, and the parasites freed of their
erythrocytes by incubationwith an equalvolume of2 mg/ml saponin
in PBS for 15 min at 37°C. The mixture was diluted with iced
PBS, centrifuged for 10 min at 1,500 g, and the free parasite pellet
was washed twice with ice-cold PBS. The pellet was frozen at
-70°C until used (within 2 wk). When enough parasite pellets
had accumulated (usually three to four), they were suspended in
10 mM Bis Tris buffer, pH 7.0, containing 1 mM PMSF, 1 mM
1,10-phenanthroline, 1001AM leupeptin, and were sonicated for 15 s
three times on ice. The sonicate was centrifuged at 100,000 g
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mM BisTris buffer, pH 7.0, with 1% Triton X-100, 1 mM PMSF,
1 mM 1,10-phenanthroline, 100 p,M leupeptin using a Dounce
homogenizer (Wheaton Scientific, Millville, NJ)(10strokes). After
30 minon ice, the extract was centrifuged at 25,000 g for 30 min,
the pellet reextracted with 4 ml more buffer, and the supernates
combined.
DEAE-Sephacel Chromatography.
￿
The extract was passed over
a 1.5 x 7-cm column of DEAE-Sephacel equilibrated in 20 mM
Bis Tris buffer, pH 7.0. The column was washed with 16 ml of
equilibration buffer, and eluted with a step of gradient of NaCl
from 0.1 to 0.7 M in 0.1 M increments. Two 8-ml fractions were
collected at each step. Fractions were assayed for aspartic protease
activity as described below. Activity eluted between 0.3 and 0.5
M. These fractions were pooled and concentrated with Centricon
10 ultrafiltration membranes to -1 ml. 0.25 volume of 1 M so-
dium acetate buffer, pH 4.5, was added. The preparation was in-
cubated on ice for 20 min and centrifuged at 4°C for 20 min at
14,000 rpm. Thesupernate was immediately neutralized with 0.125
volume 1 M Tris HCl buffer, pH 8.8.
Hydroxylapatite Chromatography.
￿
The neutralized pH 4.5 super-
nate was diluted to 12 ml with 10 mM sodium phosphatebuffer,
pH 7.0, containing 10 p,M CaCIZ, and was loaded onto a 0.8-ml
tuberculin syringecolumn of Ultrogel-HA equilibrated with the
dilution buffer. Thecolumn waswashed with this buffer and eluted
with a gradient of sodium phosphate buffer, pH 7.0, from 0 to
0.15 M containing 10 gM CaCIZ. 0.6-ml fractions were collected.
Active fractions were pooled, diluted 1:1 with 10 mM BisTzis buffer,
pH 7.0, and passed over a 0.1-ml tuberculin syringe column of
DEAE-Sephacel equilibrated in 10 mM Bis Tris buffer, pH 7.0, as
before. Thecolumn waseluted straight away with 0.3 ml of0.75 M
NaCl in 10 mM Bis Tris buffer, pH 7.0.
200SW Gel Filtration.
￿
0.2 ml of the 0.75-MDEAE elutee was
injected onto aWaters 200SW column equilibrated with PBS, using
an FPLC unit (Pharmacia Fine Chemicals). 0.4-ml fractions were
collected at a flow rate of 0.8 ml/min. The purified enzyme was
stable for longer than 1 wk on ice. Protease purification was fol-
lowed by 12% SDS-PAGE. Proteins were stained with silver (30).
Hemoglobinase Assay.
￿
Details of the assay have been described
previously (16). Briefly, 3H-leucine-labeled rat hemoglobin was in-
cubated with enzyme for 30 min at 37°C in 100 mM citrate-
phosphate buffer, pH 5.0, using a reaction volume of 30 tt1. The
incubation was stopped by addition of 1 ml oficed 6 M guanidine
HCl, and the mixture was centrifuged through a Centricon 10
ultrafiltration device (Amicon Corp.). Fragments <10 kD were
detected by assaying thefiltrate forradioactivity.An inhibitorcock-
tail containing 1 mM PMSF, 1 mM 1,10-phenanthroline, and 100
uM leupeptin was added to routine assays. Omission of this mix-
ture had no effect on total activity after the hydroxylapatite step.
Laser Desorption Mass Spectrometry.
￿
Forthis analysis, unlabeled
human hemoglobin (41AM) was incubated with purified enzyme
as described for the hemoglobinase assay. Protease inhibitors were
omitted, except as specifically noted. In some experiments, isolated
human globin a chain was prepared from the same hemoglobin
(31),andused as substrate. In other experiments, asimilar amount
of cathepsin D was substituted for the malaria enzyme. For anal-
ysis of hemoglobin degradation within digestive vacuoles, P. fal-
ciparum vacuoles were purified as previously described (16), andwere
subjectedto twocycles of freeze-thaw usingadryice-acetone bath.
This preparation was then used as theenzyme source. Wherenoted,
pepstatin was added to a final concentration of 10 /AM. The reac-
tionswere stoppedby rapid freezing in a dryice-acetone bath. The
samples were held at -70°C until used. Mass spectrometry was
962
￿
Malaria Hemoglobin Degradation
performed as has been described (32-35). Briefly, the sample to
be analyzed was mixedwith laserdesorption matrix material (satu-
rated 3,5-dimethoxy,4-hydroxy-trans-cinnamic acid in 30% acetoni-
trile/0.1% trifluoroaceticacid), dried on the metal probe tip, and
inserted into the spectrometer. The time of flight mass spectrom-
eter consisted ofaLumonics HY400neodymium/yttrium/aluminum
garnet laser(Lumonics, Inc., Ontario, Canada), thethirdharmonic
ofwhichwasfocused onto thesample throughafusedsilica window.
Theproductions so formed were accelerated by a30-kV static poten-
tial, and were detected at the end of a 2-m tube under vacuum,
using a TR88288D transient recorder (TR88288D; LeCroy Re-
search Systems Corp., Spring Valley, NY). Peak centroid determi-
nation and data reductionwere carriedoutwith aVAXworkstation.
NHZ-Terminal Sequencing.
￿
Human hemoglobin was incubated
with the purified enzyme for 30 min as above, and the products
run on an 18% reducing SDS-PAGE gel(36). Proteins were blotted
from thegel onto an Immobilon-P membrane electrophoretically
(37). After visualization of the bands with Coomassie R250, the
two peptidebands migrating faster than globin were excised and
used for sequence analysis (37). 10 residues were determined for
each peptide, allowing theirpositionsin thehemoglobin molecule
to be assigned. This experiment wasrepeated twice to confirm the
results. For analysis of the aspartic hemoglobinase sequence, par-
tially purified enzyme was subjected to electrophoresis on a 12%
reducing SDS-PAGE gel, blotted, the40-kDband excised, and se-
quenced.
Results
Aspartic Protease Purification and Properties.
￿
An aspartic pro-
teasewasisolated from an extract ofP. fakiparum trophozoites
by conventional chromatography on DEAE, hydroxylapatite,
and gelfiltration columns. Theresultant peak ofactivity was
282-fold purified over the starting material (Table 1) and
migrated as a single majorband of M40,000 by SDS-PAGE
and gel filtration (Fig. 1). Usinga saturating amount of sub-
strate, the purified enzyme cleaved rat hemoglobin with a
pH optimum of 4.5-5.0 (Fig. 2). Thespecific activity of the
purified enzyme towards hemoglobin wasapproximately twice
that of cathepsinD assayed underidenticalconditions at pH
4.5 (data not shown). The ICso for the inhibitor pepstatin
was -5 nM, indicating that the enzyme belongs to the
aspartic protease family. PMSF (1 mM), o-phenanthroline
(1 mM), andleupeptin (100 pcM),inhibitors of serine, metallo-,
Table 1.
￿
Purification of the Malaria Aspartic Hemoglobinase
Specific
Step
Triton extract
DEAE
Protein
mg
39 .1
Activity
nmol/min
5.56
Activity
nmol/min/mg
0.142
Purity
fold
1
Yield
100
concentrate 2.13 6.92 3.25 23 124
pH 4.5 cut 0.375 2.61 6.96 49 47
Hydroxyl-apatite 0.041 0.97 23.66 167 17
200 SW 0.011 0.44 40.00 282 8and cysteine proteases, respectively, had no effect on the reac-
tion . NHZTerminal sequencing revealed 9 of 22 residues
identical to the most specific mammalian aspartic protease
renin . This is greater homology than observed with most
fungal proteases in similar comparisons, equivalent to the ho-
mology between mammalian proteases, and much better than
the homology of the retroviral proteases to mammalian or
plasmodial aspartic proteases (Table 2) .
Enzyme Specificity.
￿
To define the specificity of the Plas-
modium aspartic protease towards its natural substrate hemo-
globin, the enzyme was incubated with substrate for varying
periods of time . Reactions were stopped by flash freezing and
analyzed promptly by laser desorption mass spectrometry.
This technique yields the precise molecular mass of peptides
(34, 35), which, when derived from a protein ofknown se-
quence, allows the position of the peptides in that protein
to be determined . Fig . 3 shows a time course of the reaction
between hemoglobin and the protease. At early times, two
peptide products are apparent, with mass/charge (m/z) of
3,473 and 11,670 daltons . These molecular masses correspond
precisely to those predicted for hemoglobin ot chain peptides
1-33 and 34-141 . It should be noted that this technique is
not quantitative ; there is variability in ion yield between
samples and between different peptides in the same sample
(34) . With increasing time, the two primary cleavage prod-
ucts accumulated, and other fragments appeared with masses
and assignments summarized in Table 3 . At late time points
the a34-141 peptide signal diminished, while that of a1-33
persisted . Note that all the secondary cleavage products are
fragments of the original a1-33 and 34-141 peptides . Cleavage
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within these sequences occurred only after the initial 33-34
peptide bond scission. No fragments from the (3 chain were
detected. After a 30-min incubation in the presence of the
inhibitor pepstatin, a profile indistinguishable from the zero
time point was obtained .
The ability of the enzyme to cleave isolated a chains was
3
t
E
a
300
zoo 1
100-
Figure 1 . Gel filtration on a
200SW column. The hydroxylapa-
tite-purified enzyme preparation
was injected onto a 200SW column
(Waters Instruments Inc.) using a
FPLC apparatus (Pharmacia Fine
Chemicals). The column was eluted
isocratically with PBS. 0.4-ml frac-
tions were collected and assayed for
aspartic protease activity as described
in Materials and Methods. The
column was calibrated before and
after the sample run with molecular
weight standards (Bio-Rad labora-
tories) . Peak absorbance of each
standard at A280 is shown by ar-
rows at the top of the figure. Inset :
SDS-PAGE analysis.A 50-ul aliquot
of the gel filtration peak was sub-
ject to electrophoresis on a 12%
SDS-PAGE gel under reducing con-
ditions. The gel was developed by
silver staining .
pH
6
Figure 2 .
￿
Influence ofpH on activity ofthe purified protease. Enzyme
activity was assayed using the standard Centricon 10 assay with citrate-
phosphate buffer at varied pH . Assays were performed at a saturating sub-
strate concentration of 7 .5 1.M.Malaria aspartic hemoglobinase was isolated by SDS-PAGE, transferred to a PVDF membrane, excised, and sequenced as described in experimental
procedures . All other sequences are as referenced (46-48) .
20
0 rnfn
00
Figure 3.
￿
Time course of hemoglobin degra-
dation measuredby laserdesorption mass spectrom-
etry. Purified malaria aspartic protease (activity, 0.12
pmol/min) was incubated with 4 PM humanhe-
moglobin at pH 5.0, for the times indicated. (a)
0 time (similar to incubationwith 10 p,Mpepstatin
present); (b) 5 min; (c) 15 min; (d) 30 min. Axes
are signal intensity vs. mass/charge (m/z) ratio.
Peaks in thebottom panelare numbered as assigned
in Table 2. a and 6 denote peaks corresponding
to the molecular ions of the globin chains and their
double and triple charged species. Inset: x4 en-
largement of the 11,000-14,000 region.
11000 14000
5min.
11000 14000
15 min.
11000 14000
30 min.
T
at
8
11000 14000
3 3
S
2
áp t
no 6000 10000 14000 18C
Table 2. NH2-terminal Homology to Human Renin
Sequence
No . identical
to renin
Renin T T S S V I L T N Y M D T Q Y Y G E I G I G
Cathespin D G P I P E V L K N Y M D A Q Y Y G E I G I G 14/22
CathepsinE QS AKE P L I NYLDMEYF GT I S I G 9/22
Pepsin L VDEQP L ENYLDMEYF GT I G I G 9/22
Gastricsin S V T Y E P M A Y M D A A Y F G E I S I G 9/21
HIV P Q I T L W Q R P L V T I K I G 3/16
RSV L A M T M E H K D R P L V R V I L T N T G 1/21
Penicillopepsin G V A T N T P T A N D E E Y I T P V T I G 4/21
Endothiapepsin G S A T T T P I D S L D D A Y I T P V Q I G 4/22
Rhizopuspepsin G T V P M T D Y G N D V E Y Y G Q V T I G 7/21
Yeast proteinase A G G M D V P L T N Y L N A Q Y Y T D I T L G 9/22
Aspartic hemoglobinase A G D S V T L N D V A N V M Y Y G E A Q I G 9/22Predicted masses were calculated by summation of amino acid residues
in the assigned peptides.
determined in similar fashion (Fig. 4). The enzyme was sub-
stantiallymore active with this substrate. By 5 min ofincu-
bation, most of the starting material was degraded. Again,
prominent peptides resulting from cleavage between amino
acids 33 and 34 were seen. Interestingly, a peak of m/z -
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11,307 daltons, corresponding to a1-105 was detected. The
enzyme can therefore make an initial cleavage at the 105-106
bond in an isolated a chain, but can only cleave there after
the initial 33-34 scission in native hemoglobin. After 30 min,
the peak corresponding to al-33 was the only fragment re-
maining. All other pieces were degraded to a size <2 kD,
the lower limit of detection of this method.
To confirm the assignment of fragments above, the reac-
tion products were fractionated by SDS-PAGE (Fig. 5), trans-
ferred to a PVDF membrane, and stained with Coomassie
blue. Product bands indicated with arrows were excised from
the membrane, and NHrterminal sequencing of the first 10
amino acids of each was performed. Product 1 yielded a se-
quence of LS-F-P-1Twhile product 2 had the se-
quence VLS-P-AD-KTNV These are the predicted N112-
terminal analyses for &agments a34-141 and 1-33, respectively.
Mass spectrometry of the mammalian lysosomal protease
cathepsin D incubated with hemoglobin under similar con-
ditions was also performed. 27 substantialpeaks, corresponding
to a variety ofcleavage sites, were apparent. There was a minor
peak corresponding to al-33, though no 34-141 signal. ß
chain fragments were also present (data not shown) .
Hemoglobin Degradation in Isolated Vacuoles.
￿
To compare
the fragments of hemoglobin generatedby the purified aspartic
protease with those produced within the parasite digestive
Figure 4.
￿
a globin degradation measured
by laser desorption mass spectrometry. Con-
ditions were similar to thosedescribed in Fig.
3. (a)0time (similar to 30-min incubation with
10,uMpepstatinpresent); (b)5min;(c) 30 min.
Thereis an extrapeak at m/z=11,307, not seen
in the incubations with native hemoglobin.
Inset: x2.5 enlargement ofthe 11,000-14,000
region.
Table
Peak
3. Assignment of
Mass (measured)
Mass Spectrometry
Assignment
Peaks
Mass (predicted)
dattons dattons
1 11,670 34-141 11,670
2 8,144 34-108 8,144
3 7,832 34-105 7,832
4 4,564 64-105 4,563
5 3,855 106-141 3,855
6 3,542 109-141 3,543
7 3,473 1-33 3,474
8 2,910 1-29 2,911
0 min.
11000 14000
5 min.
11000
14000Figure 5.
￿
SDS-PAGE of proteolysis products . Right lane: Hemoglobin
was incubated with malaria aspartic protease for 30 min as in Fig. 3 . An
8-25% gradient gel was run under denaturing, reducing conditions on
a Pharmacia Phastgel system (Pharmacia Fine Chemicals) . The gel was
developed by silver staining . Arrows 1 and 2 mark the two peptide frag-
ments that were transferred to PVDF from a similar but larger gel, ex-
cised, and sequenced. (Left lane) A similar incubation carried out in the
presence of 10 pM pepstatin .
vacuoles, vacuoles were purified by differential centrifugation
and density gradient fractionation, as previously described
(16) . The vacuoles were permeabilized by freeze-thaw and
incubated with exogenous hemoglobin . After 30 min, the
incubation products were analyzed by mass spectrometry (Fig.
6) . Fragments corresponding to peptides al-33 and 34-141
were the predominant species seen . The hydrolysis was abol-
ished by inclusion ofpepstatin in the incubation mixture (data
not shown) .
Discussion
Our previous studies have shown that hemoglobin pro-
teolysis in the digestive vacuoles ofmalaria parasites is an or-
2000 10000
m/z
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dered process . An aspartic protease activity is required to act
on intact hemoglobin before further degradation by other
proteases can occur (16). Aspartic protease activities have pre-
viously been partially purified fromP . lophurae (23) andP .fal-
ciparum (38), although the function and intracellular loca-
tion of these enzymes has not been defined. In this paper,
we describe an analysis ofthe cellular function ofthe malaria
aspartic hemoglobinase that initiates hemoglobin degrada-
tion. The purified enzyme differs from the previously described
activities in terms of molecular weight and pH optimum,
and as discussed below has an interesting specificity depen-
dent on the tertiary structure of its substrate . The assign-
ment of this protein to the aspartic protease family is a tenta-
tive one, and is based on inhibition by pepstatin, lack of
inhibition by other classes of protease inhibitors, and NH2-
terminal homology withknown aspartic proteases. The40%
homology to renin in a poorly conserved region ofthe aspartic
protease molecule is quite good, and suggests that the malaria
enzyme is more closely related to its mammalian host en-
zymes than to other microorganisms, which have minimal
homology to the malaria hemoglobinase in the region at issue.
Further data pertaining to the evolutionary relationships of
this protease, and confirming its aspartic mechanism, will
come from cloning and expression studies currently in progress .
Laser desorption mass spectrometry was used to identify
the peptide fragments of hemoglobin generated by the aspartic
hemoglobinase. This new method is a powerful tool for
defining the proteolytic fragments ofa protein ofknown pri-
mary structure . It is more sensitive than N142-terminal se-
quencing, much more rapid, and does not depend on prior
separation ofthe peptides generated . It is accurate to ± 0.01%,
18000
Figure 6.
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Vacuolar hemoglobin
degradation . Permeabilized vacuoles
were incubated with human hemo-
globin for 30 min atpH 5 .0 . Incu-
bation products were analyzed by
laserdesorption mass spectrometry
as detailed in Materials and Methods.
Arrows mark the peaks at m/z
= 3473 and 11,670, corresponding
to peptides al-33 and a34-141 .
Peaks corresponding to the molec-
ular ions ofmyoglobin (M used as
a calibrant, as well as a and fl
globin, are labeled. Inset: x 2.5 en-
largement ofthe 10,000-16,000 re-
gion to show the peak at 11,670
more clearly.i.e., to within one mass unit in the molecular mass range
up to -10 kD (34). This allows precise assignment of pep-
tide sequence using a simple algorithm to sum the molecular
weights ofconsecutive amino acid residues of the protein se-
quence. One other useful property of the analysis is that it
is exquisitely sensitive to the presence ofcontaminating pro-
teases in the incubation mixture. Our partially purified en-
zyme preparations were capable of making similar hemoglobin
cleavages as the purified preparation, but additionally cleaved
residues 1 and 2 from the a and R globin subunits, and res-
idue 33 from the al-33 peptide. These extraneous hydro-
lyses were due to pepstatin-insensitive exopeptidases. Further
purification removed these minor contaminants (data not
shown).
The hemoglobinase makes an initial attack between residues
a33Phe and 34Leu, and then can make subsequent cleavages
at several other sites. The 33-34 bond is located in the hinge
region ofhemoglobin. When oxygen binds to a hemoglobin
tetramer, one ot/0 dimer rotates -15 degrees around the other
(39) . Extensive salt bridges between subunits are broken, but
in the hinge region, intermolecular contacts are maintained
to keep the tetramer together (40). It is likely that a cleavage
in this area would cause unraveling of the molecule, exposing
other sites for proteolytic attack by the aspartic and other
proteases, leading to further degradation. This region of he-
moglobin is highly conserved between vertebrate species (41),
and no human variants with a homozygous mutation in this
region have been described (42). It appears that the malaria
parasite has evolved to take full advantage of the structural
features of hemoglobin.
The difference in specificity of the aspartic hemoglobinase
against native compared with fragmented or less folded he-
moglobin is striking. In the intact molecule the a33-34 site
is kinetically favored. No fragment extending from the NH2
terminus (residue 1) to a point beyond residue 33 is seen.
Once peptides 1-33 and 34-141 are generated, the protease
can go further and will cleave 34-141 into several fragments.
When isolated a chains, which have much less tertiary struc-
ture than native hemoglobin (43), are used as substrate, the
same 33-34 cleavage is made, but otherbreaks appear at the
same time. Fragment 1-105 is prominent early on. This pep-
tide arises from cleavage at 105-106 without previous cleavage
at 33-34. The aspartic protease can therefore recognize the
105-106 peptide bond as an initial attack site in the loosely
folded ot chain, but not in native hemoglobin. As might be
expected from this, degradation is much more rapid with the
isolated ot chain.
No cleavage of the /3 chain was detected with hemoglobin
as substrate for the purified protease. This suggests the exis-
tence of a (3 chain hemoglobinase in the Plasmodium diges-
tive vacuole. Alternatively, the a chain-degrading enzyme
may function much more slowly on the a chain or require
different conditions than those in our incubations. Finally,
it is possible that the /3 chain does not get degraded by the
parasite. It may be noted in Fig. 3 that the ratios of ol to
(3 chain seem to change somewhat during the incubation.
This is within the variability of the technique used, and was
not reproducible in other experiments. During the incuba-
tion, 2% of the substrate was cleaved (quantitated by cen-
tricon assay) . Loss of substrate is therefore not quantifiable
by the laser desorption mass spectroscopy technique. We
cannot fullyrule out some degradation of the /3 chain to frag-
ments too small to detect.
That the enzyme characterized here is the aspartic pro-
tease responsible for the key first step of hemoglobinolysis
in the vacuole is suggested by several observations. Most im-
portantly, an extract of the purified vacuoles is able to de-
grade hemoglobin, generating primary fragments identical
to those seen with the isolated aspartic hemoglobinase, in
a pepstatin-inhibitable reaction. Secondly, the pH ofthe diges-
tive vacuole, which has been measured to be about pH 5 (44,
45), is optimal to support activity of the aspartic hemo-
globinase. Lastly, SDS-PAGE of the purified vacuoles reveals
a protein band at Mr 40,000 (data not shown), though we
cannot be confident at this point that this band is the aspartic
protease. Confirmation of the vacuolar location of this en-
zyme will be achieved once immunolocalization can be per-
formed.
Previously, we proposed that hemoglobin degradation in
the malaria parasite digestive vacuole is a highly ordered pro-
cess (16). This paper describes the characterization of an en-
zyme that appears to play a key initial role in this catabolic
pathway. We have studied the protease's specificity with its
natural substrate. The enzyme is highly site selective when
confronted with folded protein, and not nearly as selective
when given unfolded or fragmented protein. The data pro-
vide insight into the biochemical adaptation of the malaria
organisms for survival in the host erythrocyte. Further study
of the malaria aspartic hemoglobinase should afford a better
understanding ofprotease-substrate interactions, and may allow
rational design of a new class of antimalarial agents.
Dr. Henderson died in a tragic accident while this manuscript was in preparation. We thank G. Gill and
W Trager for supplying malaria organisms, D. Atherton and J. Fernandez for protein sequence analysis,
and C. Grisostomi for technical assistance.
This work was supported by grant RF88062 from the Rockefeller Foundation.
Address correspondence to Daniel E. Goldberg, DepartmentofMolecular Microbiology, WashingtonUniver-
sity, Box 8230, 660 South Euclid Ave., St. Louis, MO 63110.
Received forpublication 19 November 1990 and in revisedform 27 December 1990.
967
￿
Goldberg et al.References
1. Rudzinska, M.A. 1965. Pinocytic uptake and thedigestionof
hemoglobin in malaria parasites.J. Protozool. 12:563.
2. Aikawa, M., P.K. Hepler, C.G. Huff, and H. Sprinz. 1966.
Thefeeding mechanismofavianmalarial parasites.) Cell Biol.
28:355 .
3. Slomianny, C., G. Prensier, and E. Vivier. 1982. Ultrastruc-
tural study of the feeding process of erythrocytic P. chabaudi
trophozoite. Mot Biochem. Parasitol (Suppl. V):695.
4. Theakston, R.D.G., K.A. Fletcher, and B.G. Maegraith. 1970.
Theuseofelectron microscope autoradiography forexamining
the uptake and degradation of haemoglobin by Plasmodium
falciparum. Ann. Trop Med. Parasitol 64:63.
5. Ting, I.P., and I.W. Sherman. 1966. Carbon dioxide fixation
in malaria-I. Kinetic studies in Plasmodium lophurae. Comp
Biochem. Physiol 19:855.
6. Sherman, I.W. 1977. Amino acid metabolism andprotein syn-
thesis in malarial parasites. Bull. WHO 55:265.
7. Pallet, H., andM.E. Conrad. 1968. Malaria: extracellular amino
acid requirements for in vitro growth of erythrocytic forms
of Plasmodium knowlesi. Proc . Soc. Exp Biol. Med. 127:251.
8. Sherman, I.W, andL. Tanigoshi. 1970. Incorporation of 14C-
amino acids by malaria. Int. J. Biochem. 1:635 .
9. Zarchin, S., M. Krughak, and H. Ginsburg. 1986. Digestion
of thehost erythrocyte by malaria parasites is theprimarytarget
for quinolone-containing antimalarials. Biochem. Pharmacol.
35 :2435.
10. Sherman, I. 1979.Biochemistry ofPlasmodium. Microbiol Rev.
43:453.
11. Fitch, C.D., R. Chevfi, H. Banyal, G. Phillips, M.A. Pfaller,
and D.J. Krogstad. 1982. Lysis ofPlasmodium falciparum by
Ferriprotoporphyrin IX andaChloroquine-Ferriprotoporphyin
IX Complex. Antimicroh Agents Chemother. 21:819.
12. Ball, E.G., R.W. McKee, C.B. Anfinsen,WO. Cruz, andQ.M.
Geiman. 1948. Studies on malarial parasites: ix. chemical and
metabolic changes during growth and multiplication in vivo
and in vitro. J Biol. Chem. 175:547.
13. Morrison, D.B., and H.A. Jeskey. 1948. Alterations in some
constituents ofthemonkey erythrocyte infected with Plasmo-
dium knowlesi as relatedto pigment formation.J. Nat. Malar.
Soc. 7:259.
14. Groman, N.B. 1951. Dynamicaspects ofthe nitrogen metab-
olism of Plasmodium gallinaceum in vivo and in vitro. J In-
fect. Dis. 88:126.
15. Roth,E.F., D.S. Brotman, J.P. Vanderberg, and S. Schulman.
1986. Malarial pigment-dependent errorin the estimation of
hemoglobin content in Plasmodium falciparum-infected red
cells. Am. J Trop Med. Hyg. 35:906.
16. Goldberg, D.E., A.F.G. Slater, A. Cerami, andG.B. Henderson.
1990. Hemoglobin degradation in the malaria parasite Plas-
modium falciparum: An orderedprocess in aunique organelle.
Proc . Nad. Acad. Sci. USA. 87:2931.
17. Cook, L., P.T. Grant, and WO. Kermack. 1961. Proteolytic
enzymes of the erythrorytic forms of rodent and simian spe-
cies of malarial plasmodia. Exp Parasitol. 11:372.
18 . Levy, M.R., and S.C. Chou. 1973. Activityand some proper-
ties of an acid proteinase from normal and Plasmodium berghei-
infected red cells. J Parasitol. 59:1064.
19 . Levy, M.R., WA. Siddiqui, and S.C. Chou. 1974. Acid pro-
tease activity in Plasmodium falciparum and P. knowlesi and
ghosts oftheirrespective host redcells. Nature (Lond.). 247:546.
20. Hempelmann, E., and R.J.M. Wilson. 1980. Endopeptidases
from Plasmodium knowlesi. Parasitology. 80:323.
968
￿
Malaria Hemoglobin Degradation
21. Aissi, E., P. Charet, S. Bouquelet, and J. Biguet. 1983. En-
doprotease in Plasmodium yoelii nigeriensis. Come Biochem.
Physiol 74B:559.
22. Gyang, F.N., B. Poole, and W Trager. 1983. Peptidases from
Plasmodium falciparum cultured in vitro. Mot Biochem. Pbmsitol.
5:263.
23. Sherman, I.W, and L. Tanigoshi. 1983. Purification of Plas-
modium lophurae cathepsin D and its effects on erythrocyte
membrane proteins. Mot Biochem. Parasitol. 8:207.
24. Vander Jagt, D.L., C. Intress, J.E. Heidrich, J.E.K. Mrema,
K.H. Rieckmann, and H.G. Heidrich. 1982. Markerenzymes
ofPlasmodium falciparum andhumanerythrocytes as indicators
of parasite purity.J. Parasitol 68:1068.
25 . Sato,K., YFukabori, andM. Suzuki. 1987. Plasmodium ber-
ghei: a study of globinolytic enzyme in erythrocyte parasite.
Zbl. Bakt. Hyg. A 264:487.
26 . Rosenthal, P.J., J.H. McKerrow, M. Aikawa, H. Nagasawa,
andJ.H. Leech. 1988. A malarial cysteine proteinase is neces-
sary for hemoglobin degradation by Plasmodium falciparum.
J. Clin. Invest. 82:1560.
27. Fagan,J.M., L. Waxman,andA.L. Goldberg. 1986. Redblood
cells contain apathwayforthedegradation ofoxidant-damaged
hemoglobin that does not require ATP or ubiquitin. J. Biol.
Chem. 261:5705.
28 . Trager, W., andJ.B. Jensen. 1976. Human malaria parasites
in continuous culture. Science (Wash. DC). 193:673.
29. Lambros, C., and J.P. Vanderberg. 1979. Synchronization of
Plasmodium falciparum erythrocytic stages in culture. J. Par-
asitol 65:418.
30. Wray, W., T Boulikas, V.P. Wray, and R. Hancock. 1981.
Silver staining of proteins in polyacrylamide gels. Anal. Bio-
chem. 118:197.
31 . Huisman, T .H.J., and J.H.P. Jonxis. 1977. The Hemoglo-
binopathies. Marcel Dekker, Inc., New York. pp. 192.
32. Beavis, R.C., andBT Chait. 1989. Cinnamic acid derivatives
as matrices for ultraviolet laser desorption mass spectrometry
of proteins. Rap Comm. Mass Spec . 3:432.
33 . Beavis, R.C., and B.T. Chait. 1989. Matrix-assisted laser-
desorption mass spectrometry using 355 nm radiation. Rap
Comm. Mass Spec. 3:436.
34. Beavis, R.C., and BT Chait. 1990. High accuracy molecular
mass determination of proteins using matrix assisted laser
desorption mass spectrometry. Anal Chem. 62:1836.
35. Beavis, R.C., and BT Chait. 1990. Rapid, sensitive analysis
of protein mixtures by mass spectrometry. Proc . Nat Acad.
Sci. USA. 87:6873.
36. Laemmli, U.K. 1970. Cleavage of structural proteins during
assembly of the head of bacteriophage T4. Nature (Lond.).
227:680.
37. Matsudaira, P 1987. Sequence from picomole quantities ofpro-
teins electroblotted onto polyvinylidene difiuoride membranes.
J. Biol. Chem. 262:10035.
38. Vander Jagt, D.L., L.A. Hunsaker, and N.M. Campos. 1986.
Characterization of a hemoglobin-degrading, low molecular
weight protease from Plasmodium falciparum. Mot Biochem.
Parasitol. 18:389.
39. Baldwin, J., andC. Chothia. 1979. Haemoglobin: The struc-
turalchanges related to ligand bindingand itsallosteric mech-
anism. J. Mot Biol. 129:175 .
40. Perutz, M. 1987. TheMolecularBasisofBloodDiseases. W.B.
Saunders, Co., Philadelphia. pp. 127-178.
41. Dickerson, R.E., and I. Geis. 1983. Hemoglobin. Benjamin/Cummings, Menlo Park, CA. pp. 68.
42. Bunn, H.F. and B.G. Forget. 1986. Hemoglobin: Molecular,
Genetic and Clinical Aspects. W.B. Saunders Co., Philadel-
phia. pp. 381-451.
43 . Beychok, S., I. Tyuma, R.E. Benesch, and R. Benesch. 1967.
Optically active absorption bands of hemoglobin and its
subunits. J. Biol. Chem. 242:2460.
44. Krogstadt, D.J., P.H. Schlesinger, and I.Y. Gluzman. 1985.
Antimalarials increase vesicle pH in Plasmodium falciparum.
J. Cell Biol. 101:2302.
45. Yayon, A., Z.I. Cabantchik, and H. Ginsburg. 1984. Iden-
969
￿
Goldberg et al.
tification of theacidic compartment ofPlasmodium falciparum-
infected human erythrocytes as the target of the antimalarial
drug chloroquine. EMBO (Eur. Mol. Biol. Organ.)J. 3:2695.
46. Azuma, T, G. Pals,T.K. Mohandas,J.M. Couvreur, andR.T.
Taggart. 1989. Human gastric cathepsin E. J. Biol. Chem.
264:16748.
47. Weber, IT, M. Miller, M. Jaskolski, J. Leis, A.M. Skalka, and
A. Wlodawer. 1989. Molecular modeling of the HIV-1 pro-
teaseandits substratebindingsite. Science(Wash. DC).243:928.
48. Tang,J., and R.N.S. Wong. 1987. Evolution in the structure
and function of aspartic proteases. J. Cell. Biochem. 33:53.